Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Talma Brenner

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Journal of Neuroimmunology|January 8, 2008
A disease-specific fraction isolated from IVIG is essential for the immunosuppressive effect of IVIG in experimental autoimmune myasthenia gravisSara Fuchs, Tali Feferman, Roberto Meidler, et al.
Experimental Neurology|March 23, 2015
Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors--Recommendations for methods and experimental designsMario Losen, Pilar Martinez-Martinez, Peter C Molenaar, et al.
Pharmacological Research|August 12, 2019
MicroRNA signature associated with treatment response in myasthenia gravis: A further step towards precision medicinePaola Cavalcante, Tehila Mizrachi, Claudia Barzago, et al.
JCI Insight|April 14, 2017
Preconditioned mesenchymal stem cells treat myasthenia gravis in a humanized preclinical modelMuriel Sudres, Marie Maurer, Marieke Robinet, et al.
International Immunopharmacology|March 18, 2020
RIC3, the cholinergic anti-inflammatory pathway, and neuroinflammationYael Ben-David, Sara Kagan, Hagit Cohen Ben-Ami, et al.
Brain : a Journal of Neurology|June 23, 2026
Relative frequencies of muscle specific kinase antibody myasthenia in 46 centres worldwideAngela Vincent, Rehab Badi, Nina Barisic, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Journal of Neuroimmunology|January 8, 2008
A disease-specific fraction isolated from IVIG is essential for the immunosuppressive effect of IVIG in experimental autoimmune myasthenia gravisSara Fuchs, Tali Feferman, Roberto Meidler, et al.
Experimental Neurology|March 23, 2015
Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors--Recommendations for methods and experimental designsMario Losen, Pilar Martinez-Martinez, Peter C Molenaar, et al.
Pharmacological Research|August 12, 2019
MicroRNA signature associated with treatment response in myasthenia gravis: A further step towards precision medicinePaola Cavalcante, Tehila Mizrachi, Claudia Barzago, et al.
JCI Insight|April 14, 2017
Preconditioned mesenchymal stem cells treat myasthenia gravis in a humanized preclinical modelMuriel Sudres, Marie Maurer, Marieke Robinet, et al.
International Immunopharmacology|March 18, 2020
RIC3, the cholinergic anti-inflammatory pathway, and neuroinflammationYael Ben-David, Sara Kagan, Hagit Cohen Ben-Ami, et al.
Brain : a Journal of Neurology|June 23, 2026
Relative frequencies of muscle specific kinase antibody myasthenia in 46 centres worldwideAngela Vincent, Rehab Badi, Nina Barisic, et al.
Pageof 5